AS
Publicaties op Oncologisch.com
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer ...
RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc ...
RNA-signaturen en pCR bij neoadjuvant pertuzumab-trastuzumab: WSG-ADAPT-HER2+ analyse
Gede-escaleerd neoadjuvant pertuzumab-trastuzumab met of zonder paclitaxel bij HER2-positief mammacarcinoom: PHERGain definitief
PlanB studie: adjuvant EC-docetaxel versus docetaxel-cyclofosfamide bij mammacarcinoom